We have been making some updates on the site. If you have any issues with FAST Graphs, please clear your cache and cookies and that will likely resolve any issues with accessing the site.

Research Articles

Teva Pharmaceutical Has It All: Value, Growth and Yield


Research Articles

Headquartered in Israel, Teva (TEVA) is the world’s largest generic drug maker, which markets over 1200 molecules in over 60 countries throughout the world. In addition to their generic portfolio, Teva also possesses a strong branded portfolio led by Copaxone, the world’s leading injectable therapy for multiple sclerosis. Teva generates high levels of cash flow, […]

6 High Yield Pharmaceutical Companies: Do They Justify the Risk?


Research Articles

Introduction Today Investors are keenly focused on income while simultaneously very risk averse.This current behavior brings with it a level of frustration.The appetite for yield is high precisely at a time when yields on the traditionally safest investments like bonds and CDs, etc. are at historic lows.On the other hand, dividend yields on many blue-chip […]

3 Consecutive Double-Digit Years for the S&P 500?


Research Articles

The question posed by the title of this article is whether or not 2011 will be the third year in a row of double-digit returns for the S&P 500. In calendar year 2009 the S&P 500 returned 26.4% and followed this up in 2010 by earning 15.06%. As we look forward to 2011 we see […]

10 Dividend Stocks Poised for Growth


Research Articles

As 2011 begins, the growing legion of investors seeking retirement income is faced with the same conundrum they faced in 2010. Interest rates remain at near all-time lows, and severely limit attractive investment options to meet income needs. After being traumatized by the great recession of 2008, safety and risk aversion are of the highest […]

The S&P 500 2010 Target of 1254 Reached


Research Articles

On September 5, 2010, we published an article on Seeking Alpha that suggested that the S&P 500 would reach 1245 by year end. Then on November 2, 2010 we republished our fair value S&P 500 calculation based on updated earnings forecasts by Standard & Poor’s Corp. The new forecast implied that the S&P 500 would […]

Principles of Valuation Part 3: The Key to Avoiding the Obvious Mistakes


Research Articles

In this, our 12th and final installment of our series of articles on when and why to buy a stock, we will focus on how to use the principles of valuation to avoid obvious mistakes. As mentioned in previous articles, investing is never a game of perfect. The best that an investor can hope for […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.